| 4ARK: reference: Optimization of allosteric MEK inhibitors. Part 1: Venturing into underexplored SAR territories., Hartung IV, Hitchcock M, Puhler F, Neuhaus R, Scholz A, Hammer S, Petersen K, Siemeister G, Brittain D, Hillig RC, Bioorg Med Chem Lett. 2013 Apr 15;23(8):2384-90. doi: 10.1016/j.bmcl.2013.02.028., Epub 2013 Feb 14. PMID: 23474388 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).